Cardiac arrest & resuscitation

Extracorporeal cardiopulmonary resuscitation (ECPR) eligible refractory out of hospital cardiac arrests – A post-hoc analysis of the EVIDENCE randomised controlled trial and Registry

ResuscitationPublished Secondary analysis of the EVIDENCE randomised trial and Registry

Authors' conclusion

Only a small percentage of OHCA patients were considered eligible for ECPR, predominantly due to challenges in accessing ECPR therapy. ECPR-eligible patients, not treated with ECPR, have very poor survival outcomes.

Study context

Population
Refractory out-of-hospital cardiac arrest (OHCA) patients in the EVIDENCE randomised controlled trial (RCT) and contemporaneous EVIDENCE RegistryRCT and Registry combined
Participants
1,497 patients
Primary endpoint
ECPR eligibility (meeting ECPR criteria, arriving to an ECPR-capable hospital within 1 h of arrest, no sustained ROSC, within ECPR service hours)
Methodological detailspre-specified, post-hoc analysis, RCT and contemporaneous registry (non-randomised data)
  • Pre-specified
  • Post-hoc analysis
  • RCT and contemporaneous registry (non-randomised data)

Primary result

As reported in the abstract

Truly eligible for hospital-based ECPR

Truly eligible for hospital-based ECPR

38

3%

Further findings

Potential ECPR candidates

Potential hospital-based ECPR candidates
79 (5%)
Potential pre-hospital ECPR candidates
350 (23%)

Reasons for exclusion of potential ECPR patients

Arrival to hospital >1-h post-arrest, arrival to a non-ECPR-capable centre, and/or arrival outside ECPR-capable hours

Survival to hospital discharge of potential ECPR patients

Survival to hospital discharge
5%

Original publication

ECPR eligible refractory out of hospital cardiac arrests – A post-hoc analysis of the EVIDENCE randomised controlled trial and Registry. Resuscitation. Published 29 January 2026. doi:10.1016/j.resuscitation.2026.110996

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.